| Raj et al. IPOS-Renal validation. PMID 29729346 |
Advanced kidney disease; cross-sectional validation |
Multi-symptom measurement |
Not an intervention study |
| Ju et al. Fatigue core measure workshop. PMID 29551585 |
Haemodialysis stakeholders including patients |
Makes fatigue a measurable core outcome |
Consensus, not prevalence |
| Tong et al. SONG-HD workshop. PMID 27497527 |
International patient/professional workshop |
Core outcome domains |
Dialysis-focused |
| Evangelidis et al. Delphi survey. PMID 28238554 |
International haemodialysis stakeholders |
Patient-priority ranking |
Participation and language selection |
| Hughes et al. Life-participation measure. PMID 40569671 |
Two SONG consensus workshops; 130 participants, 18 countries |
Core life-participation measure endorsed by consensus |
Explicitly not yet piloted or validated in non-KRT CKD |
| Schade van Westrum et al. fatigue study. PMID 40599823 |
414 patients across non-dialysis CKD, dialysis and transplant; nationwide descriptive survey (not qualitative) |
Stage-specific fatigue burden, discussion and treatment gaps |
Single-country sample; self-report; no comparator |
| James et al. online community analysis. PMID 32673242 |
Self-report online community |
Symptom and treatment-experience breadth |
Self-selection; diagnoses not uniformly verified |
| Wong et al. foregoing-dialysis review. PMID 35285915 |
41 cohorts, 5,102 patients |
Survival, quality, utilization and place of death |
Heterogeneous observational cohorts |
| Buur et al. CKM vs dialysis review. PMID 34507554 |
25 observational studies |
Survival and QoL trade-off |
Strong treatment selection bias |
| Scherer et al. kidney palliative-care program. PMID 31295050 |
Ambulatory program description |
Service-model evidence |
Descriptive, no causal comparator |
| Agarwal et al. symptom feedback pilot. PMID 37993776 |
Cluster pilot in haemodialysis |
Feasibility of routine symptom feedback |
Pilot scale; clinical effectiveness unresolved |
| Fishbane et al. KALM-1. PMID 31702883 |
378 haemodialysis patients with pruritus |
Quantitative itch and QoL response |
Dialysis-only and 12-week horizon |